Peptides crossing the blood-brain barrier: some unusual observations.
about
Nanoparticles for brain drug deliverySerum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implicationsLinking Activation of Microglia and Peripheral Monocytic Cells to the Pathophysiology of Psychiatric DisordersThe potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's diseaseThe area postrema: a brain monitor and integrator of systemic autonomic stateDisrupted sleep without sleep curtailment induces sleepiness and cognitive dysfunction via the tumor necrosis factor-α pathwayObesity and dementia: adipokines interact with the brain.Inhibition of cocaine binding to the human dopamine transporter by a single chain anti-idiotypic antibody: its cloning, expression, and functional properties.Melanin-concentrating hormone functions in the nervous system: food intake and stress.The hypocretins: setting the arousal threshold.Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphinsAdipokines and the blood-brain barrierNorepinephrine mediates the transcriptional effects of heterotypic chronic stress on colonic motor functionGastrointestinal hormone actions in the central regulation of energy metabolism: potential sensory roles for the circumventricular organs.Cytokine signaling modulates blood-brain barrier function.The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes.The hypocretin/orexin system: an increasingly important role in neuropsychiatry.The Emerging Therapeutic Role of NGF in Alzheimer's Disease.The Blood-Brain Barrier: Regulatory Roles in Wakefulness and Sleep.An activated triple bond linker enables 'click' attachment of peptides to oligonucleotides on solid supportHypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells.Nerve growth factor (NGF) has novel antidepressant-like properties in rats.Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development.Passage of progesterone into the brain changes with photoperiod in the ewe.Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats.Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms.Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats.Does IL-6 release ACTH by exerting a direct effect in the rat anterior pituitary.Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.The effect of intravenous corticotropin-releasing hormone administration on esophageal sensitivity and motility in health.Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor.
P2860
Q21285117-DFA97B7E-0F9F-4A95-9468-E9B1A8E37D0BQ24649095-52A4EF1F-C78D-4544-A8CA-2DACA7DD1D3FQ26745417-9916E09F-EFE9-4D5B-BE93-15DE2E1FEC0CQ26853347-3FD5AE25-EB9D-45C0-8922-BA071A2AA43EQ28261066-6398553A-03EB-45A4-9627-7605E1B6C12FQ28387166-2CD8BB19-A1B9-4470-B8B8-DEB4B2B84201Q30361051-90E98375-FE4C-414D-AFEE-48E872325DA8Q34216604-413A29AD-DC66-44DB-B100-B1BD52E4277AQ34217708-97B2F773-E447-49BE-BACC-425FDACADAA3Q34623823-9723AB9E-96B4-4FFE-9064-7A9373990D47Q35835788-A006AA07-4115-4BD2-9700-8B08875B9E7EQ36088883-CDA8FFC6-8C16-4F7E-B421-721D9388D69FQ37231312-0912AA3B-368B-424B-9E86-47215C5DD73DQ37442579-27E3718E-B0B0-4765-890B-BF15C0423471Q37612092-87276BC6-79BD-475B-BD26-77DA2FE623F5Q38033144-DC1592BB-72DA-4763-92E5-8DE15ECFC8E3Q38231949-109D0950-6D16-45B0-934A-D6E4CD6B28C2Q38708387-37617DC6-F93B-4830-B433-E2014D8D40F0Q38770872-ACF27535-2CEF-493B-B478-0439D2D6D989Q38855792-D15F5022-4EA7-4FE6-A72B-6C2B48CC350FQ39793168-03DAA433-EFED-45BC-9E2D-6B8BB4585105Q41199023-2B290CED-DC02-4E99-BF48-14D44854DADBQ44295855-0C311D58-FA8F-4C56-B982-81E9BCC99973Q44553328-C8848400-5BD1-4600-82A2-2C860A05B6A9Q44709356-D2631C25-FD51-4630-A7F8-1A0D311AD83CQ44928894-FF8CCAD0-30B5-4BFF-A6D9-B07C66F0154DQ44941884-0D6FAE85-CB23-49FF-90B6-F1DAE8E1AD14Q47743864-9130F349-8DAB-4A43-B693-9417051B30AFQ48304534-18048744-5DF4-4BF3-B94E-6E0DBF029518Q51088978-5DE5026E-4FBE-483A-865E-90C0495C1B27Q52291688-777C5F2E-B519-405C-B77F-43FD1501F4C9
P2860
Peptides crossing the blood-brain barrier: some unusual observations.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Peptides crossing the blood-brain barrier: some unusual observations.
@ast
Peptides crossing the blood-brain barrier: some unusual observations.
@en
type
label
Peptides crossing the blood-brain barrier: some unusual observations.
@ast
Peptides crossing the blood-brain barrier: some unusual observations.
@en
prefLabel
Peptides crossing the blood-brain barrier: some unusual observations.
@ast
Peptides crossing the blood-brain barrier: some unusual observations.
@en
P1433
P1476
Peptides crossing the blood-brain barrier: some unusual observations.
@en
P304
P356
10.1016/S0006-8993(99)01961-7
P407
P577
1999-11-01T00:00:00Z